Richard Louis Ferrero - Infectious Diseases

Author Information

Richard Louis Ferrero is a distinguished researcher affiliated with the Gastrointestinal Infection and Inflammation group at the Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, located in Clayton, Victoria, Australia. He is also associated with the Department of Microbiology at Monash University, Clayton, VIC, Australia. His work primarily focuses on the study of gastrointestinal infections and the intricate immune responses to such conditions.

Research Contributions

Richard Louis Ferrero has made significant contributions to the field of infectious diseases, with a particular emphasis on the pathogenesis of Helicobacter pylori and its role in gastrointestinal diseases, including gastric carcinogenesis. His research delves into understanding the innate immune responses to Helicobacter pylori and the molecular mechanisms that facilitate bacterial infections and their progression. His work on the regulation of immune functions by Nod1 and the investigation of potential drug targets for gastrointestinal tract infections has been influential in advancing the field. Ferrero's research has implications for the development of vaccines and therapeutics targeting infectious diseases.

Aliases

Richard Louis Ferrero is also known by several aliases including Richard L. Ferrero, Richard Ferrero, R L Ferrero, and R. L. Ferrero. These variations are commonly used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers Published	145
Total Citations	9,252
H-index	46

Publications:

Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells.

DOI: 10.1016/j.celrep.2020.108677

Year: 2021

Helicobacter pylori Xanthine-Guanine-Hypoxanthine Phosphoribosyltransferase-A Putative Target for Drug Discovery against Gastrointestinal Tract Infections.

DOI: 10.1021/acs.jmedchem.0c02184

Year: 2021

Analysis of Innate Immune Responses to Helicobacter pylori.

DOI: 10.1007/978-1-0716-1302-3_17

Year: 2021

Helicobacter pylori-induced gastric carcinogenesis

DOI: 10.1016/b978-0-323-85563-1.00004-6

Year: 2021

Nuclear trafficking of bacterial effector proteins

DOI: 10.1111/cmi.13320

Year: 2021

Vaccines

DOI: 10.1007/s40278-020-80475-6

Year: 2020

Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid Tissue.

DOI: 10.1053/j.gastro.2020.03.009

Year: 2020

Constitutive STAT3 serine phosphorylation promotes Helicobacter-mediated gastric disease.

DOI: 10.1016/j.ajpath.2020.01.021

Year: 2020

Nod1 Promotes Colorectal Carcinogenesis by Regulating the Immunosuppressive Functions of Tumor-Infiltrating Myeloid Cells

DOI: 10.2139/ssrn.3622484

Year: 2020

NOD1 mediates interleukin-18 processing in epithelial cells responding to Helicobacter pylori infection

DOI: 10.21203/rs.3.rs-49701/v1

Year: 2020

What Career Opportunities Exist for ID Specialists?

What are the Applications of Parasite DNA Analysis?

How Does the NIH Support Global Health?

What is Plasmodium?

How do Infectious Diseases Affect Pregnancy?

What is the Importance of International Collaboration?

What are the Future Directions in Antimicrobial Therapies?

What Are the Challenges in Implementing AI?

What are the Treatment Options for Fatigue in Infectious Diseases?

How is Zika Virus Transmitted?

Partnered Content Networks

Relevant Topics